» Articles » PMID: 36724989

Adverse Pregnancy Outcomes and Long Term Risk of Ischemic Heart Disease in Mothers: National Cohort and Co-sibling Study

Overview
Journal BMJ
Specialty General Medicine
Date 2023 Feb 1
PMID 36724989
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the associations between five major adverse pregnancy outcomes and long term risks of ischemic heart disease in mothers.

Design: National cohort study.

Setting: Sweden.

Participants: All 2 195 266 women with a first singleton delivery in Sweden during 1973-2015.

Main Outcome Measures: The main outcome measure was incidence of ischemic heart disease from delivery to 2018, identified from nationwide inpatient and outpatient diagnoses. Cox regression was used to calculate hazard ratios for ischemic heart disease associated with preterm delivery, small for gestational age, pre-eclampsia, other hypertensive disorders of pregnancy, and gestational diabetes, adjusting for other adverse pregnancy outcomes and maternal factors. Co-sibling analyses assessed for confounding by shared familial (genetic and environmental) factors.

Results: During 53.6 million person years of follow-up, ischemic heart disease was diagnosed in 83 881 (3.8%) women. All five adverse pregnancy outcomes were independently associated with increased risk of ischemic heart disease. In the 10 years after delivery, adjusted hazard ratios for ischemic heart disease associated with specific adverse pregnancy outcomes were 2.09 (95% confidence interval 1.77 to 2.46) for other hypertensive disorders of pregnancy, 1.72 (1.55 to 1.90) for preterm delivery, 1.54 (1.37 to 1.72) for pre-eclampsia, 1.30 (1.09 to 1.56) for gestational diabetes, and 1.10 (1.00 to 1.21) for small for gestational age. The hazard ratios remained significantly increased even 30-46 years after delivery: 1.47 (1.30 to 1.66) for other hypertensive disorders of pregnancy, 1.40 (1.29 to 1.51) for gestational diabetes, 1.32 (1.28 to 1.36) for pre-eclampsia, 1.23 (1.19 to 1.27) for preterm delivery, and 1.16 (1.13 to 1.19) for small for gestational age. These findings were only partially (<45%) explained by shared familial (genetic or environmental) factors. Women who experienced multiple adverse pregnancy outcomes showed further increases in risk (eg, <10 years after delivery, adjusted hazard ratios associated with 1, 2, or ≥3 adverse pregnancy outcomes were 1.29 (1.19 to 1.39), 1.80 (1.59 to 2.03), and 2.26 (1.89 to 2.70), respectively)).

Conclusions: In this large national cohort, women who experienced any of five major adverse pregnancy outcomes showed an increased risk for ischemic heart disease up to 46 years after delivery. Women with adverse pregnancy outcomes should be considered for early preventive evaluation and long term risk reduction to help prevent the development of ischemic heart disease.

Citing Articles

Women's experience of gestational diabetes and healthcare in southern Sweden - a qualitative study.

Bjork Javanshiri A, Modig S, Nymberg P, Calling S BMC Pregnancy Childbirth. 2025; 25(1):224.

PMID: 40021994 PMC: 11869633. DOI: 10.1186/s12884-025-07328-2.


Heart disease in pregnancy and adverse outcomes: an umbrella review.

Zhang J, Ren Y, Li B, Cao Q, Wang X, Yu H Front Med (Lausanne). 2025; 12:1489991.

PMID: 39975686 PMC: 11836018. DOI: 10.3389/fmed.2025.1489991.


Life course trajectories of maternal cardiovascular disease risk factors by obstetric history: a UK cohort study using electronic health records.

Birnie K, Howe L, Jones T, Madley-Dowd P, Martin F, Forbes H BMC Med. 2025; 23(1):91.

PMID: 39948598 PMC: 11827161. DOI: 10.1186/s12916-025-03937-y.


Pre-pregnancy BMI modifies the associations between triglyceride-glucose index in early pregnancy and adverse perinatal outcomes: a 5-year cohort study of 67,936 women in China.

Li L, Zhou Y, Li H, Li J, Huang L, Wu W Diabetol Metab Syndr. 2025; 16(1):311.

PMID: 39762964 PMC: 11702117. DOI: 10.1186/s13098-024-01550-2.


Cardiovascular Disease Among Women and Birthing Individuals After Delivering a Child With Congenital Heart Disease.

Colello S, Ittenbach R, Klepczynski B, Mangeot C, Burnham N, Messersmith A JACC Adv. 2024; 4(1):101434.

PMID: 39720582 PMC: 11666928. DOI: 10.1016/j.jacadv.2024.101434.


References
1.
Parikh N, Gonzalez J, Anderson C, Judd S, Rexrode K, Hlatky M . Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021; 143(18):e902-e916. DOI: 10.1161/CIR.0000000000000961. View

2.
Siddiqui N, Hladunewich M . Understanding the link between the placenta and future cardiovascular disease. Trends Cardiovasc Med. 2012; 21(7):188-93. DOI: 10.1016/j.tcm.2012.05.008. View

3.
Honigberg M, Chaffin M, Aragam K, Bhatt D, Wood M, Sarma A . Genetic Variation in Cardiometabolic Traits and Medication Targets and the Risk of Hypertensive Disorders of Pregnancy. Circulation. 2020; 142(7):711-713. PMC: 7436942. DOI: 10.1161/CIRCULATIONAHA.120.047936. View

4.
Gogineni V, Manfrini D, Aroda S, Zhang Y, Nelson D, Egerman R . Variations in Awareness of Association Between Adverse Pregnancy Outcomes and Cardiovascular Risk by Specialty. Cardiol Ther. 2021; 10(2):577-592. PMC: 8555062. DOI: 10.1007/s40119-021-00220-y. View

5.
Honigberg M, Zekavat S, Aragam K, Klarin D, Bhatt D, Scott N . Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy. J Am Coll Cardiol. 2019; 74(22):2743-2754. PMC: 6981240. DOI: 10.1016/j.jacc.2019.09.052. View